Literature, news and videos pertinent to
The Bobbi Johnson Filipiak
Patient Communications Program

 Daily News Update

Selected lung cancer articles—updated daily

Go to Today's Update

INHERIT EGFR - Studying Germline EGFR Mutations (INHERIT) —ClinicalTrials.gov

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Corsello, S.M., Nagari, R.T., Spangler, R.D. et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling. Nat Cancer (2020) doi:10.1038/s43018-019-0018-6

Chemo-Sensitivity Testing for Lung Cancer:
Dr. Robert Nagourney & Ryan Kuper

 News feed below courtesy of MedWorm:

widget @ surfing-waves.com


The Bobbi Johnson Filipiak Patient Communications Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

For more information about this special program, please click on...

  1. Main
  2. About
  3. Photos
  4. Inspiration
  5. Memories

Donate

We also accept PayPal™

paypal.me/ICANadvocacy



Guidestar Platinum Seal of Transparency 2021
Pacfic Medical Training, PMT's Best of Medical Nonprofit Sites Winner 2014
All Star Award 2015 Winner Constant Contact


Federal Tax I.D.: EIN 86-0818253